UNH
SHORTINSIDER SELLCONGRESS BUYCONGRESS SELLUNITEDHEALTH GROUP INC
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.
News Summary
NeutralUnitedHealth delivered strong operational execution in H1 2026 with significant earnings beats and multiple guidance raises, driven by improved medical cost management and favorable reserve releases. However, the company faces material headwinds from DOJ criminal and civil investigations into Medicare Advantage billing practices, membership declines from affordability pressures, and expanded antitrust scrutiny of its Claritev unit.
Red flags
- •DOJ criminal investigation into Medicare Advantage billing practices and diagnosis inflation allegations
- •DOJ expanded antitrust investigation into Claritev unit with new civil investigative demands alleging collusion
- •Membership declines: 525,000 loss in Q2 alone; guidance for 500,000 ACA and 1.1M Medicare Advantage losses in 2026
- •Regulatory pressure from proposed flat Medicare Advantage payment increases and federal transparency rules on PBM operations
- •Material reliance on prior-period reserve releases ($860M in Q2) to drive earnings recovery, raising sustainability concerns
Funds Reducing / Exiting (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Appaloosa LP | David Tepper | 90K | -110,000 | $24M | 1.0% | -55% | Existing |
| Viking Global | Andreas Halvorsen | 0 | −1.2M | — | 1.0% | -100% | EXITED |
| Berkshire Hathaway | Warren Buffett | 0 | −5.0M | — | 0.6% | -100% | EXITED |
Shares Held reflects quarter-end positions for partial reductions. Funds that fully exited show 0 shares held. ∆ Shares is the change from the prior quarter. % of Fund is the prior-quarter position size — how much of the book was sold down.
Insider Activity
Congressional Trading
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Maria Elvira Salazar | house | FL27 | SELL | $1,001 - $15,000 | 2026-06-04 | 2026-07-07 | ↗ |
| John Boozman | senate | — | BUY | $1,001 - $15,000 | 2026-06-04 | 2026-07-13 | ↗ |
| Alan Armstrong | senate | — | BUY | $15,001 - $50,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.